N. Albareda, N. Rosenberg, S. Roth, I. Zsolt, T. Rosen, and A. A. Hebert, “Ozenoxacin, a Novel, Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients with Impetigo: Phase III Clinical Trials Pooled Analysis Results”, J of Skin, vol. 1, no. 3.1, p. s102, Oct. 2017.